Home › Neurocrine Biosciences surges after release of study results
 

Keywords :   


Neurocrine Biosciences surges after release of study results

2015-01-08 18:21:29| Biotech - Topix.net

Shares of Neurocrine Biosciences surged Thursday after drug development partner AbbVie said their potential treatment for endometriosis-related pain fared well in late-stage research. AbbVie said early results from the first of two phase three studies of the drug showed that doses of elagolix met the study's main goals of reducing non-menstrual pelvic pain and menstrual pain in patients with endometriosis.

Tags: results study release biosciences

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
More »